Surya Pharmaceutical Limited, an integrated pharmaceutical company, researches, manufactures, and markets pharmaceuticals products and services in India and internationally. The company offers a range of active pharmaceutical ingredients and intermediates in various categories, including cephalosporin antibiotics, betalactum antibiotics, and penemms; and menthol and mint products comprising menthol oil, crystals, and powder. It also provides ethical formulations in finished dosage forms, such as anti-biotics, PPIs, cough and cold remedies, and calcium and multi-vitamin supplements under the Alexus brand; generic formulations, including anti-infectives, gastro-intestinals, NSAIDS, anti-allergics, nutraceuticals, anthelmintics, ophthalmologicals, parentrals, herbals, etc. under the Aegis brand; and diagnostic and medical equipment under the Altair brand. In addition, the company markets diabetic footwear, sports nutrition products, and baby care products, as well as a range of skin and cosmetic products under various international brands. Further, it offers contract/custom research and manufacturing services for the life science industry; and is involved in the development of Pyto-pharma project. Surya Pharmaceutical Limited was founded in 1992 and is headquartered in Delhi, India.